On September 10, FANGZHOU JIANKE hosted its 10th H2H Medical Service Ecosystem Conference in Shanghai. At the event, FANGZHOU JIANKE (06086) made a significant announcement with the launch of its self-developed "Smart Core for Chronic Disease Management" - the Xingshi Medical Large Model. This major release represents not only FANGZHOU JIANKE's proactive response to the national "AI+" initiative, but also provides breakthrough technological solutions to core industry challenges including "low efficiency in traditional chronic disease management," "insufficient service precision," and "difficulty in utilizing doctors' fragmented time." The model is expected to become the core technological foundation driving comprehensive upgrades in the "AI + Chronic Disease Management" sector.
FANGZHOU JIANKE Launches Xingshi Medical Large Model
As the company's "super digital brain" and "powerful intelligent hub," the Xingshi Medical Large Model has first established a foundational capability system encompassing image and voice recognition, natural language understanding, massive medical and pharmaceutical knowledge storage, and reasoning capabilities. Additionally, leveraging its SOTA (State-of-the-Art) level performance in medical domain large models, it integrates five intelligent agents - knowledge, triage guidance, pre-consultation, doctor, and electronic medical records - into FANGZHOU JIANKE's "digital intelligent service team," achieving comprehensive closed-loop coverage of the entire chronic disease management service chain.
Furthermore, built upon the competitive moat of the "familiar doctor-patient relationship" business model and the powerful technological foundation of the Xingshi Medical Large Model, FANGZHOU JIANKE's technical team has developed "Five Core AI Products" serving three major ecosystems of doctors, patients, and industry partners: AI Medication Finder, AI Health Manager, AI Doctor's Assistant, AI Academic Assistant, and AI-Powered Search. This product suite constitutes the robust technological backbone of FANGZHOU JIANKE's "AI + Chronic Disease Management Services," capable of providing patients with more precise and efficient internet medical services in real-time.
Notably, at this H2H Medical Service Ecosystem Conference, the localized "OpenEvidence" - Xingshi AI Academic Assistant - made its debut as the first clinical decision support tool for doctors based on legitimate literature support from the Chinese Medical Association's literature database and enhanced by Xingshi large model performance. According to the introduction, the Xingshi AI Academic Assistant features smooth voice interaction capabilities, supporting second-level voice broadcasting of expert-level answers. This functionality is well-suited to the busy clinical scenarios of doctors while deepening tool usage stickiness.
During the on-site demonstration, users simply needed to input voice commands such as "Interpret the 2024 revised hypertension guidelines, highlighting key differences compared to the 2018 revised hypertension guidelines," and the Xingshi AI Academic Assistant would search and match relevant information, efficiently generate comparative reports, and complete real-time voice broadcasting. A frontline expert commented after learning about it: "The analytical capability, reasoning ability, and comprehension ability are all impressive. The Xingshi AI Academic Assistant could become a 'voiceprint-level medical brain' for clinical doctors."
As an internet medical enterprise deeply rooted in chronic disease management, technological innovation has always been a crucial foundation for FANGZHOU JIANKE's development. From proposing the industry-innovative "H2H (Hospital To Home) Smart Medical Ecosystem" to achieving the significant "AI + H2H" upgrade, the company's digital transformation path has been firm and clear: In 2022, rapid exploration and multi-dimensional mining of practical application scenario demands for medical AI; In 2023, intelligent customer service assistant went live; In 2024, successive integration of capability-rich, high-computing-power large models to empower knowledge base construction and popular science article generation tasks. In 2025, development of self-researched medical large models covering the entire chronic disease management chain, further releasing the value of scientific research achievements.
Currently, the "AI+" action plan released by the State Council is accelerating empowerment across various industries. The healthcare sector, being closely related to people's welfare, will inevitably become an important practice field. FANGZHOU JIANKE will deeply grasp this era's opportunities and integrate into the development landscape. Moving forward, the company will use the Xingshi Medical Large Model as a fulcrum to continue deepening the research and development of "AI + Chronic Disease Management" application scenarios, practicing the mission of "making everyone healthier" through technological strength, and continuously injecting corporate innovation momentum into the high-quality development of the internet medical industry!